Decision support. Everything on this page is structured for clinician review before it reaches the chart. ChironAI surfaces and ranks; the licensed clinician decides. ChironAI does not make a regulatory clearance claim; see Disclosures.
Most clinical AI waits to be asked. ChironAI™ CDS reasons at the moment of intake — for a single presenting picture it proposes the symptoms most worth screening, the prior conditions most likely in play, and the one missing data point that would most change the differential. This is the agentic intelligence inside the product, powered by Eve-Healthcare™ F5/reasoner: the system does the cognitive legwork, surfaces it ranked and explained, and the clinician keeps every decision.
From the chief complaint alone, Chiron ranks the symptoms worth screening for by diagnostic yield — naming the differentials each one separates, where it is captured, and which are time-critical red flags. The review of systems stops being a static checklist and becomes a reasoned, case-specific shortlist.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Separates: Heart failure · COPD
Separates: Stable angina · Acute coronary syndrome · Severe aortic stenosis
Separates: Iron-deficiency anemia (GI vs. gynecologic source)
Separates: Heart failure · Nephrotic syndrome · Venous insufficiency
Separates: Hypothyroidism
Separates: Atrial fibrillation · Anemia-driven tachycardia
Separates: Obstructive sleep apnea contributing to fatigue
Tailored to this specific patient, Chiron ranks the pre-existing conditions worth confirming — each with its clinical impact on the work-up and the exact screening questions that confirm or exclude it. The prior that would change everything stops hiding in an unread chart.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Reframes the dyspnea work-up and raises the priority of an echocardiogram and a BNP.
Screening questions
A common, reversible driver of fatigue and exertional dyspnea — and one that mandates a source work-up.
Screening questions
Explains the full symptom cluster and is inexpensive to confirm.
Screening questions
Raises the pre-test probability for the exertional chest-pressure pathway.
Screening questions
Would change rate, rhythm, and anticoagulation strategy if present.
Screening questions
Before recommending anything, Chiron flags what it does not yet know — and ranks the gaps by how much resolving each would move the differential. Knowing the highest-yield missing value is often worth more than another opinion on the values you already have.
Must review before final
Decision-support output. Clinician review and attestation required before this content is signed into the chart.
Anemia is a high-likelihood, reversible driver of this presentation and is currently unmeasured.
The heart-failure pathway cannot be confirmed or excluded without it.
Hypothyroidism is cheap to confirm and explains the whole symptom cluster.
A beta-blocker, statin, or thyroid medication would shift several priors.
This is what agentic clinical reasoning looks like in a regulated setting: the system takes initiative — it screens, ranks, flags, and names its own blind spots — but it never crosses into deciding. Every output here carries a must-review-before-final gate, and no recommendation enters the chart without a clinician’s signature. That is the bounded agency the architecture is built to hold.
Read: agency, not autonomy →